Alterity Therapeutics Ltd (ATHE) Stock Price, Quote, News & History

ATHENASDAQ
$4.99
-0.04-0.80%
At close: Jul 15, 5:00 PM EST
$5.08
0.091.80%
After Hours: 4:23 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
-7.50M
Financing Cash Flow (TTM)
44.41M
Free Cash Flow (TTM)
-17.70M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
19.21M

Analyst Trends and Forecast

2
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$56.11M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.44
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-11.71%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.06

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$127.10K
Total Cash
-
Debt to Equity
0.00
Issuance of Debt (TTM)
-$127.10K
Repayment of Debt (TTM)
-$127.10K

Key Statistics

Open
$5.05
Close
$4.99
Volume / Avg.
24.92K / 50.87K
Day Range
$4.94 - $5.16
52 Wk Range
2.66 - 7.00
Market Cap
$92.08M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
0.22%
Days to Cover
1.17

About

Sector
Health Care
Industry
Biotechnology
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's diseas...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Alterity Therapeutics (ATHE) stock?

A

You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alterity Therapeutics (ATHE) competitors?

A

There are no as such competitors for Alterity Therapeutics.

Q

What is the forecast, or price target, for Alterity Therapeutics (ATHE) stock?

A

Alterity Therapeutics has a consensus price target of $10.50.

Q

What is the current price for Alterity Therapeutics (ATHE)?

A

The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $5.08 last updated July 15, 2026 at 4:23 PM EDT.

Q

Does Alterity Therapeutics (ATHE) pay a dividend?

A

There are no upcoming dividends for Alterity Therapeutics.

Q

When is Alterity Therapeutics (NASDAQ:ATHE) reporting earnings?

A

Alterity Therapeutics does not have any upcoming earnings scheduled.

Q

Is Alterity Therapeutics (ATHE) going to split?

A

There is no upcoming split for Alterity Therapeutics.

Q

What sector and industry does Alterity Therapeutics (ATHE) operate in?

A

Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.